Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues.
It has previously been reported that intracerebroventricular (i.c.v.) administration of leptin induced adipose tissue apoptosis in addition to influencing lipid metabolism. The objective of the present study was to determine if the expressions of peroxisome proliferator-activated receptor-gamma (PPAR gamma), uncoupling protein-2 (UCP2), and tumor necrosis factor (TNF alpha) were influenced by in vivo leptin treatment. Expression of PPAR gamma, UCP2, and TNF alpha in epididymal fat tissue was examined by Western immunoblot and in situ immunocytochemical analysis after 5 days of i.c.v. leptin treatment. Young and old rats (3 and 8 months old) were treated with or without 5 micrograms/d leptin. Leptin treatment increased PPAR gamma expression by 70-80% (P < 0.01) in both age groups. Leptin treatment decreased the expression of UCP2 (P < 0.01) in young rats, whereas it increased UCP2 expression (P < 0.01) in old rats. Leptin treatment also decreased TNF alpha expression by 40% (P < 0.01) in young rats but did not influence its expression in old rats. The basal level of expression of PPAR gamma was greater in 3-month-old rats than in 8-month-old rats. The basal level of UCP2 and TNF alpha expression was not different between the two age groups. These immunoblotting data were further confirmed by in situ immunocytochemical analysis. The present study suggests that expression of PPAR gamma may be directly involved in the leptin-induced adipocyte apoptosis signal pathway, whereas UCP2 and TNF alpha may play roles in the leptin-induced lipolysis process.
Qian
H
H
Department of Foods and Nutrition, University of Georgia, Athens 30602, USA.
Hausman
G J
GJ
Compton
M M
MM
Azain
M J
MJ
Hartzell
D L
DL
Baile
C A
CA
D000273:Adipose Tissue / Q000187:drug effects*; D000367:Age Factors; D000818:Animals; D004822:Epididymis; D005786:Gene Expression Regulation; D007150:Immunohistochemistry; D007276:Injections, Intraventricular; D007473:Ion Channels; D020738:Leptin; D008297:Male; D026901:Membrane Transport Proteins; D008830:Microbodies / Q000378:metabolism; D024101:Mitochondrial Proteins; D014176:Protein Biosynthesis; D011506:Proteins / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018160:Receptors, Cytoplasmic and Nuclear / Q000096:biosynthesis*; D014157:Transcription Factors / Q000096:biosynthesis*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*; D000071246:Uncoupling Protein 2
D007473:Ion Channels; D020738:Leptin; D026901:Membrane Transport Proteins; D024101:Mitochondrial Proteins; D011506:Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D014409:Tumor Necrosis Factor-alpha; C000604391:Ucp2 protein, rat; D000071246:Uncoupling Protein 2